CMH — Chordate Medical Holding AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK0.95m
- -SEK3.30m
- SEK0.66m
Brief: Chordate Proposes Directed Issue And Rights Issue Of Units Totalling About SEK 30 Mln
Brief: Chordate Medical Holding Gets Patent In The U.S.
Brief: Chordate Medical Holding: Studies For Chronical Migraine And Chronical Rhinitis Put On Hold Due To COVID-19
Brief: Chordate Medical Holding Q4 Revenue Sek 0.3 Million
Brief: Chordate Medical Holding: Directed New Share Issue Was Fully Subscribed
Brief: Chordate Carries Out Directed Issue With Proceeds Of SEK 7.4 Mln
Brief: Chordate Medical Holding Chooses PO-MEDICA As Distributor
Brief: Chordate Medical Holding Q3 Pre-tax Loss Flat At SEK 6.4 Mln
Brief: Chordate's Distributor Vedise Extends Sales Area
Brief: Chordate Medical Carries Out Planned Rights Issue
Brief: Chordate Medical Holding Gets Additional Order From Italy
Brief: Chordate Medical Holding Q2 Loss After Tax Narrows To SEK 6.1 Mln
Brief: Chordate Medical Holding Raises SEK 10 Million Before Issue Costs In Directed New Share Issue
Brief: Chordate Medical Holding Carries Out Rights Issue
Brief: Chordate Carries Out Directed New Share Issue Of Up To SEK 10 Mln
Brief: Chordate's Distributor Secures Market Permission For Israel
Brief: Chordate Medical Q1 Pretax Loss Narrows To SEK 6.3 Million
Brief: Chordate Completes Study Of Intranasal Kinetic Oscillation Stimulation
Brief: Chordate Medical Holding Unit Gets Order In Italy